A world leader
  in patient-centered care


Training the next generation
  of cancer researchers


The most advanced
  treatment options available


Myles Brown, MD, elected to the National Academy of Sciences

May 05, 2016

Myles Brown, MD, Brown, director of the Center for Functional Cancer Epigenetics at Dana-Farber Cancer Institute, has been elected to The National Academy of Sciences.

Discover Care Believe - boy on pier

"Discover. Care. Believe." highlights Dana-Farber breakthroughs

Dana-Farber Cancer Institute has launched DiscoverCareBelieve.org, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.

What do you #DiscoverCareBelieve?

Charles Fuchs, MD, MPH

New Online Resource for Precision Cancer Medicine

Clinicians at Dana-Farber/Brigham and Women's Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.

Dana-Farber and Fitbit partner to test if weight loss can prevent breast cancer recurrence
April 27, 2016

Dana-Farber is teaming up with Fitbit to test if weight loss can help prevent breast cancer recurrence among overweight women with early stage disease. This first of its kind study has potential to create a new standard of treatment for millions of breast cancer patients around the world.

William G. Kaelin, Jr., MD, receives Princess Takamatsu award from AACR
April 21, 2016

William G. Kaelin, Jr., MD, of Dana-Farber has received the 10th annual Princess Takamatsu Award for "novel and significant work" in cancer from the American Association for Cancer Research (AACR).

Anti-PD-1 immunotherapy boosts long-term survival in metastatic melanoma
April 17, 2016

One-third of patients with metastatic melanoma in a phase 1 clinical trial have survived five years after treatment with the immunotherapy drug nivolumab, which blocks the PD-1 immune checkpoint, reports a Dana-Farber Cancer Institute scientist.

Genomic makeup of colorectal cancers predicts immune system ability to fight tumors, study suggests
April 14, 2016

Colorectal cancers heavily bedecked with tumor-related proteins called neoantigens are likely to be permeated with disease-fighting white blood cells, researchers at Dana-Farber report in a new study.

Fitbits Could Help Find New Breast Cancer Treatments (Boston Magazine)

April 28, 2016

Dr. Jennifer Ligibel is leading research to see if weight loss can prevent breast cancer recurrence.

New Test Diagnoses Cancer Faster, Offers Patients Better Treatment (WBZ-TV Boston)
April 28, 2016

Researchers at Dana Farber helped develop a new test called a Rapid Heme Panel to diagnose patients faster.

Childhood Cancer Survivors Often Feel Older Than Their Years (Health Day)
April 22, 2016

A study led by Dr. Lisa Diller shows surviving a childhood cancer can take a toll on health, and that young adults who've been through the ordeal often feel aged before their time.


Biden to cancer researchers: How can we move faster on this? (The Washington Post)
April 21, 2016

Dr. William Kaelin Jr., said to accelerate President Obama's "moonshot" initiative, collaboration among researchers is critical.

Bristol’s Opdivo Shows Benefits in Cancer Immunotherapy Trial (Wall Street Journal)
April 18, 2016

Dr. F. Stephen Hodi led a study showing more than one-third of advanced melanoma patients treated with the immunotherapy drug Opdivo have survived at least five years.

Many older black women miss out on targeted breast cancer drug (FOX News)
April 18, 2016

Dr. Rachel Freedman comments on a study showing older black women with human epidermal growth factor receptor 2 (HER2)–positive breast cancer are less likely than their white peers to receive targeted therapy.


Children’s cancer research is often ignored. Make it a ‘moonshot’ priority (Boston Globe)
April 14, 2016

Dr. David A. Williams, president of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, comments on why pediatric cancers should be a priority for research funds.

Susan G. Komen Adds 16 Breast Cancer Research Leaders as Komen Scholars and Advisors (Breast Cancer News)
April 13, 2016

Drs. Kornelia Polyak, Tari King and Jennifer Ligibel are new leaders in breast cancer research and advocacy for the Komen Scholars international advisory group.


Live Music and Meditation (Thursdays)

May 05, 2016

2:15 PM - 3:00 PM

Stoneham Patient Services Suite, Smith Bldg., Room 330

Explore how music can help you decrease stress, anxiety, and pain, as well as guide you to a place of increased relaxation.

Program led by the Leonard P. Zakim Center's Expressive Therapies Manager, Heather Woods, MT-BC. Open to DFCI patients, family members and staff.

To register, please contact the Zakim Center at Zakim_Center@dfci.harvard.edu or 617-632-3322


Join us at the first SoulMates Gala

May 05, 2016

6:30 PM - 10:00 PM

MacDowell Hall at the Meadowbrook School of Weston

Join us for a night of food and laughter to celebrate the first anniversary of the SoulMates program.


The SoulMates Gala will be an evening to celebrate and honor influential friends of the program, Dr. Eric Winer and Judith Schlager, followed by a performance by the one and only, Loretta LaRoche!


For more information and to register, click here: http://danafarbersoulmates.weebly.com/


Ticket prices: 


  • Members of the SoulMates program - $50
  • Guests - $125
  • Table - $1,500*
    *Includes reserved seating for 10 guests and a private V.I.P. cocktail reception with our honorees from 6:00 - 6:30 PM.

Sponsorship opportunities are available. Please contact Angelique Tung at aftung_2000@yahoo.com.




May 06, 2016

10:00 AM - 11:30 AM

Smith Building, Room 330

In this class you will learn exercises of the mind/body through mindfulness awareness and fluid movement. These techniques will help you to relax, increase concentration, while utilizing the mind, body and spirit to help improve quality of life. This class is open to patients who have been newly diagnosed with cancer, are receiving treatment, or in remission. Family, friends and staff are welcome. Please call the Zakim Center to register at 617-632-3322 or email Zakim_Center@dfci.harvard.edu.


  • Patient referral information, clinical resources and more.

  • Make an Appointment

    For adults:

    Quick access: Appointments as soon as the next day for new adult patients

    For children:

    Request Appointment Online

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button
  • Top-ranked

    • U.S. News Best Hospitals Cancer 2015-2016 logo    U.S. News Best Children's Hospitals Cancer 2015-2016 logo 

    Top-ranked cancer center in New England for adults (with Brigham and Women's Hospital) — #1 in the nation for children (with Boston Children's Hospital)

  • Dana-Farber Blog

    Insight Blog screenshot

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now

5/5/2016 5:59:06 PM